RECOMBITEK Canine ParvoThis page contains information on RECOMBITEK Canine Parvo for veterinary use.
The information provided typically includes the following:
- RECOMBITEK Canine Parvo Indications
- Warnings and cautions for RECOMBITEK Canine Parvo
- Direction and dosage information for RECOMBITEK Canine Parvo
RECOMBITEK Canine ParvoThis treatment applies to the following species:
Modified Live Virus
DESCRIPTION: RECOMBITEK® Canine Parvo contains canine parvovirus, propagated in a stable cell line. Safety and efficacy of this product have been demonstrated by vaccination and challenge tests.
INDICATIONS: RECOMBITEK® Canine Parvo is recommended for the vaccination of healthy dogs 6 weeks of age and older for prevention of disease due to canine parvovirus.
DOSAGE: Aseptically inject 1 mL (1 dose) subcutaneously or intramuscularly into healthy dogs. For primary vaccination, revaccinate with a second 1 mL dose 2 to 3 weeks later. Dogs younger than 12 weeks of age should be revaccinated with a single 1 mL dose every 2 to 3 weeks, the last dose given at or over 12 weeks of age. Revaccinate annually with a single 1 mL dose.
PRECAUTIONS: Store at 2-7°C (35-45°F). Do not use chemicals to sterilize syringes and needles. Burn container and all unused contents. Contains gentamicin as a preservative. It is generally recommended to avoid vaccination of pregnant dogs. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine.
SOLD TO VETERINARIANS ONLY.
For Veterinary Use Only.
RECOMBITEK is a registered trademark of MERIAL.
Manufactured By MERIAL INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, Qc, H9X 3V1, Canada
50 x 1 Dose (1 mL)
3239 SATELLITE BLVD., DULUTH, GA, 30096
Copyright © 2022 Animalytix LLC. Updated: 2021-12-02